Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Market · Equity
$241.23
+$4.1182 · +1.74%
· Aug 21, 4:00 PM ET
$241.23
Previous close+$4.1182 · +1.74%
· Aug 21, 4:00 PM ET
$241.3
+$4.19 · +1.77%
Regular session · ET · Market data may be delayed.
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Fund assets
476.57M USD
Expense ratio
0.35%
NAV
$241.12
Average volume
5.69K
Volume
11.01K
Day range
$237.71 – $243.16
52-week range
$160.91 – $244.04
Previous close
$237.11
Price change
1 day
+1.74%
1 month
+18.50%
3 months
+30.56%
Year to date
+27.46%
1 year
+46.79%
3 years
+50.01%
5 years
+11.92%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 24, 2026.
Portfolio composition
Fund income
Dec 22, 2025
Annual
Dec 22, 2025
Dec 26, 2025
$0.9565
Dec 23, 2024
Annual
Dec 23, 2024
Dec 24, 2024
$1.2517
Dec 18, 2023
Annual
Dec 19, 2023
Dec 22, 2023
$0.7127
Dec 19, 2022
Annual
Dec 20, 2022
Dec 23, 2022
$0.749
Dec 20, 2021
Annual
Dec 21, 2021
Dec 27, 2021
$0.397
Dec 21, 2020
Annual
Dec 22, 2020
Dec 28, 2020
$0.608
Dec 23, 2019
Annual
Dec 24, 2019
Dec 30, 2019
$0.472
Dec 20, 2018
Annual
Dec 21, 2018
Dec 27, 2018
$0.551
Dec 18, 2017
Annual
Dec 19, 2017
Dec 22, 2017
$0.683
Dec 19, 2016
Annual
Dec 21, 2016
Dec 23, 2016
$0.327
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
